Benzinga | Aug 7, 2020 07:32AM EDT

Arbutus Biopharma Q2 EPS $(0.25) Misses $(0.24) Estimate, Sales $1.51M Miss $1.74M Estimate

Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.24) by 4.17 percent. This is a 45.65 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $1.51 million which missed the analyst consensus estimate of $1.74 million by 12.99 percent. This is a 116.29 percent increase over sales of $700.00 thousand the same period last year.